Cholinergic Agents
Showing 1 - 25 of 5,512
Deprescriptions, Antidepressive Agents, Antipsychotic Agents Trial in Bielefeld, Munich, Witten (PARTNER intervention, Control
Recruiting
- Deprescriptions
- +5 more
- PARTNER intervention
- Control intervention
-
Bielefeld, Germany
- +2 more
Apr 24, 2023
Hyperhidrosis, Oxybutynin, Sweat Gland Diseases Trial in São Paulo (Topical oxybutynin spray, Topical spray, Oral oxybutynin)
Not yet recruiting
- Hyperhidrosis
- +6 more
- Topical oxybutynin spray
- +2 more
-
São Paulo, SP, BrazilIrmandade da Santa Casa de Misericórdia de São Paulo
Oct 27, 2021
Cholinergic Integrity in Down Syndrome in Association With
Recruiting
- Down Syndrome
- +2 more
- [18F]-FEOBV Radiotracer
-
Nashville, TennesseeVanderbilt University Medical Center Clinical Research Center
Jan 31, 2023
Postmenopausal Symptoms, Aging, Alzheimer Trial in Nashville, Burlington (Cholinergic antagonist)
Recruiting
- Postmenopausal Symptoms
- +2 more
- Cholinergic antagonist
-
Nashville, Tennessee
- +1 more
Mar 23, 2022
Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease
Completed
- Pulmonary Disease, Chronic Obstructive
- Tiotropium+Olodaterol
- +3 more
-
Taiwan, ChinaHealth Data Research Center, National Taiwan University
Jan 3, 2023
Cardiac Arrhythmia, Supraventricular Arrhythmia Trial in Lodz (Comparison of atropine and isoprenaline)
Not yet recruiting
- Cardiac Arrhythmia
- Supraventricular Arrhythmia
- Comparison of atropine and isoprenaline
-
Lodz, PolandDepartment of Electrocardiology Medical University of Lodz
Oct 9, 2023
Autism Spectrum Disorder, Aggression, Irritability Trial in New Haven (Transdermal nicotine, Transdermal )
Completed
- Autism Spectrum Disorder
- +2 more
- Transdermal nicotine
- Transdermal placebo
-
New Haven, ConnecticutYale University
May 4, 2022
Hallucinations, Auditory, Psychosis Trial in New Haven (Rivastigmine Transdermal Product, Scopolamine, Placebo)
Recruiting
- Hallucinations, Auditory
- Psychosis
- Rivastigmine Transdermal Product
- +2 more
-
New Haven, ConnecticutConnecticut Mental Health Center
Mar 2, 2022
COPD Exacerbation Trial in Copenhagen (Long acting muscarinic antagonists (LAMAs) at bedtime)
Recruiting
- COPD Exacerbation
- Long acting muscarinic antagonists (LAMAs) at bedtime
-
Copenhagen, DenmarkHerlev-Gentofte Hospital
Jan 30, 2023
During Hyperventilation in Normal Individuals and in Mild and
Recruiting
- Hyperventilation
- +2 more
- Acute Hyperventilation
- +2 more
-
Clayton, Victoria, AustraliaMonash Medical Centre
Oct 3, 2022
Mood Disorders, Healthy, Unipolar Depression Trial run by the NIMH (Scopolamine Nasal Spray)
Terminated
- Mood Disorders
- +3 more
- Scopolamine Nasal Spray
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 17, 2021
Prokinetic Use After Emergency Intestinal Anastomosis Trial in Sohag (Prokinetic Motility Agents as primpiram and gastreg)
Active, not recruiting
- Prokinetic Use After Emergency Intestinal Anastomosis
- Prokinetic Motility Agents as primpiram and gastreg
-
Sohag, EgyptOf medicine, Sohag university hospital
Apr 30, 2022
COPD Exacerbation, Magnesium Sulfate Trial in Lahore (Nebulized Magnesium Sulphate)
Completed
- Chronic Obstructive Pulmonary Disease Exacerbation
- Magnesium Sulfate
- Nebulized Magnesium Sulphate
-
Lahore, Punjab, PakistanFawad Ahmad Randhawa
Jan 22, 2023
Alzheimer Trial in Mineola (Donepezil Hydrochloride, Placebo)
Completed
- Alzheimer Disease
- Donepezil Hydrochloride
- Placebo
-
Mineola, New YorkWinthrop-University Hospital
Jan 13, 2021
Cold Urticaria, Cold Contact Urticaria, Symptomatic Dermographism Trial in Berlin (CDX-0159)
Active, not recruiting
- Cold Urticaria
- +4 more
-
Berlin, GermanyCharite University
Dec 20, 2022
Visualising Cerebral and Peripheral Cholinergic Nerves in
Recruiting
- Dementia With Lewy Bodies
- +3 more
- PET-CT using FEOBV
- +3 more
-
Aarhus N, DenmarkDepartment of Nuclear medicine and PET, Aarhus University Hospit
May 19, 2022
Rheumatoid Arthritis Trial in United States (SetPoint Medical Neurostimulation of the Cholinergic Anti-inflammatory Pathway
Active, not recruiting
- Rheumatoid Arthritis
- SetPoint Medical Neurostimulation of the Cholinergic Anti-inflammatory Pathway System
-
Aventura, Florida
- +3 more
Apr 22, 2021
Cholinergic Urticaria Trial in Germany (LEO 152020, LEO 152020 )
Completed
- Cholinergic Urticaria
- LEO 152020
- LEO 152020 placebo
-
Aachen, Germany
- +5 more
Sep 1, 2022
Delirium on Emergence Trial in Zagazig (ketofol, dexmedetomidine, normal saline)
Completed
- Delirium on Emergence
- ketofol
- +2 more
-
Zagazig, Alsharqia, EgyptFaculty of medicine, zagazig university
Jul 15, 2022
Cocaine Dependence Trial in São Paulo (Biperiden, Placebo)
Completed
- Cocaine Dependence
- Biperiden
- Placebo
-
São Paulo, BrazilUDED - Drug Dependence Unit
Sep 18, 2020
Inflammation Trial in Las Cruces (Occipito-Atlantal Decompression (OA DC), Sham Occipito-Atlantal Decompression (Sham OA DC),
Recruiting
- Inflammation
- Occipito-Atlantal Decompression (OA DC)
- +5 more
-
Las Cruces, New MexicoBurrell College of Osteopathic Medicine
Jan 28, 2022
Patients Suffered Substance Abuse Related Voiding Dysfunction
Recruiting
- Voiding Dysfunction
- Substance Abuse
- First line treatment: oral NSAID and anticholinergic agents
- +3 more
-
Shatin, Hong KongPrince of Wales Hospital
Mar 9, 2022
Subjective Cognitive Decline Trial in Nashville (Mecamylamine Challenge, Placebo Comparator Challenge)
Recruiting
- Subjective Cognitive Decline
- Mecamylamine Challenge
- Placebo Comparator Challenge
-
Nashville, TennesseeVanderbilt University Medical Center
Dec 19, 2022
Schizophrenia, Schizoaffective Disorder, Healthy Trial in New Haven (11C-EMO - A Novel PET Radiotracer for Muscarinic M1
Recruiting
- Schizophrenia
- +2 more
- 11C-EMO - A Novel PET Radiotracer for Muscarinic M1 Receptor
-
New Haven, ConnecticutConnecticut Mental Health Center
Sep 16, 2022